Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1219

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 1219
---
 required to file income tax returns in various States. The Company is subject to income tax examinations by federal and state
taxing authorities. The taxable years that are open under federal and state statute of limitations are 2020 through 2024. Due to net
operating loss carryforwards that remain unutilized, such loss carryforwards remain subject to review until utilized.

A
reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 SCHEDULE
OF UNRECOGNIZED TAX BENEFITS

    Year ended
                                                                                December
31, 2024  
    Year
ended
                                                                               December 31, 2023 
  
    Balance at the beginning
    of the year 
     -  
     - 
  
    Increases
    related to positions taken in prior years 
     26,768  
       - 
  
    Balance
    at the end of the year 
    $26,768  
    $- 

NOTE
14 – SUBSEQUENT EVENTS

In
accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined
that the following events require disclosure.

On
or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the
“Amendment”), approved by the disinterested members of the Company’s Board of Directors. Pursuant to the
Amendment, DBR has been given until August 31,2025 to lend to the Company a minimum of $2.0
million, and until December 31, 2026 to lend to the Company the balance of up to $5.7
million. The Amendment also substantially reduces the interest rate for the first $2
million that may be advanced by DBR Capital from 38.5%
to 18.75%
per annum, and further substantially reduces the interest rate to 10%
per annum (also from 38.5%)
for any amounts loaned in excess of $2
million.

On
March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000
in aggregate value of shares of the Company’s common stock, par value $0.001 per share, through March 6, 2026. As of the date of
this filing